MicroRNAs and multiple sclerosis: from physiopathology toward therapy

Author： Zare-Shahabadi Ameneh   Renaudineau Yves   Rezaei Nima  

Publisher： Informa Healthcare

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.17, Iss.12, 2013-12, pp. : 1497-1507

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Blood-Brain Barrier in Multiple Sclerosis: microRNAs as Key Regulators

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 2, 2015-03 ,pp. : 157-167

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs in cancer therapy

By Rossbach Michael  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 8, 2012-08 ,pp. : 743-745

Informa Healthcare

Access to resources Recommend Favorite

Biology and therapy of micro-RNAs

By  

Reproductive BioMedicine Online, Vol. 13, Iss. 4, 2006-10 ,pp. : 580-580

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

MicroRNAs in the Pathobiology of Multiple Myeloma

By  

Current Cancer Drug Targets, Vol. 12, Iss. 7, 2012-09 ,pp. : 823-837

Bentham Science Publishers

Access to resources Recommend Favorite

MicroRNAs and Cancer Therapy – From Bystanders to Major Players

By  

Current Medicinal Chemistry, Vol. 20, Iss. 29, 2013-09 ,pp. : 3561-3573

Bentham Science Publishers

Access to resources Recommend Favorite